The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Inovio Pharmaceuticals, Inc(NASDAQ:INO) 
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely design...
Website: http://www.inovio.com
Founded: 1999
Full Time Employees: 190
CEO: J. Joseph Kim
Sector: Healthcare
Industry: Biotechnology
Inovio Pharmaceuticals Number of Twitter Followers
Inovio Pharmaceuticals Days Payable Outstanding ttm (DPO)
Inovio Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Inovio Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Inovio Pharmaceuticals Op Cashflow Per Share ttm
Inovio Pharmaceuticals Free Cashflow Per Share ttm
Inovio Pharmaceuticals Cash Per Share ttm
Inovio Pharmaceuticals P/S ratio ttm
Inovio Pharmaceuticals (GAAP) P/E ratio ttm
Inovio Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.